Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Stephen Chmura"'
Autor:
Nicholas S. Heaton, Robert J. Debs, Girija Dhamdhere, Leiping Zeng, Drew Endy, Tara Pande, Marie La Russa, David B. Lewis, Lei S. Qi, Laine E. Goudy, Augustine Chemparathy, Yanxia Liu, Stephen Chmura, Timothy R. Abbott, Xueqiu Lin
The outbreak of the coronavirus disease 2019 (COVID-19), caused by the Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2), has infected more than 100,000 people worldwide with over 3,000 deaths since December 2019. There is no cure for COVI
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e5d72f63d2187eb900abad2055862ecf
Autor:
Laine E. Goudy, Girija Dhamdhere, Stephen Chmura, Timothy R. Abbott, Lei S. Qi, Drew Endy, Marie La Russa, Augustine Chemparathy, Nicholas S. Heaton, Yanxia Liu, Xueqiu Lin, Robert J. Debs, David B. Lewis, Leiping Zeng, Tara Pande
Publikováno v:
Cell
The coronavirus disease 2019 (COVID-19) pandemic, caused by the SARS-CoV-2 virus, has highlighted the need for antiviral approaches that can target emerging viruses with no effective vaccines or pharmaceuticals. Here, we demonstrate a CRISPR-Cas13-ba
Autor:
Timothy D. Heath, Robert J. Debs, Stephen Chmura, Alice Ye, Chakkrapong Handumrongkul, Sarah Ursu, Ron G. Rosenfeld
Publikováno v:
Journal of the Endocrine Society. 5:A550-A551
Recombinant human growth hormone (rhGH), the mainstay of hGH replacement therapy, is injected daily for years to enable children to achieve normal stature. Daily rhGH injections are required because its serum-T1/2 is 230 days; 2) Concurrently, hGH-in
Autor:
Stephen Chmura, Yong Liu, Ryan J Ice, David B. Lewis, Liliana Soroceanu, Alice L. Ye, Robert Thistle, Denny Liggitt, Methawee Myers, Chakkrapong Handumrongkul, Mohammed Kashani-Sabet, Robert J. Debs, Sarah Ursu, Marissa Mack, Timothy D. Heath
Publikováno v:
Science Advances
HEDGES, a tunable nonviral DNA-based gene therapy platform, durably expresses human therapeutic proteins in immunocompetent mice.
Recombinant adeno-associated virus (AAV) vectors are transforming therapies for rare human monogenic deficiency dis
Recombinant adeno-associated virus (AAV) vectors are transforming therapies for rare human monogenic deficiency dis
Autor:
Sadia Dimbil, Jon A. Kobashigawa, Yuhei Kobayashi, Vasavi Ramachandran, Kira Y. Dionis-Petersen, William F. Fearon, Kiran K. Khush, Takeshi Nishi, Helen Luikart, Stephen Chmura, David B. Lewis, Dong-Hyun Choi
Publikováno v:
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation. 37(4)
The aim of this study was to determine the value of the ratio of the percentage of circulating regulatory cluster of differentiation 4 T cells (%Tregs) to the percentage of endothelial progenitor cells (%EPCs; Treg/EPC ratio) for predicting clinicall